Abstract
Background
The social or familial factors influencing the location chosen for end-of-life (EOL) care for terminally ill breast cancer patients are unknown.
Methods
We retrospectively analyzed 195 patients with recurrent or progressive breast cancer who received anticancer treatment at the National Cancer Center Hospital between January 2008 and May 2012. Detailed data concerning the patients’ demographic, familial, and clinical characteristics were collected, and multivariate and Cox logistic regression analyses were performed to evaluate the impact of these characteristics on the place of EOL care and on survival, respectively.
Results
Sixty-eight patients (34.9 %) died in a hospital, 26 patients (13.3 %) at home, and 101 patients (51.8 %) in hospice. Most of the patients having caregivers received EOL care at palliative care facilities (hospice or home) [odds ratio (OR) 2.57; 95 % confidence interval (CI) 1–6.6; p = 0.05]. In contrast, patients with factors suggesting a clinically severe status (performance status ≥2, use of opioids, delirium, and ascites) more often received EOL care in a hospital. Among patients who received EOL care at hospice or home, patients with minor children received EOL care at home (OR 0.08; 95 % CI 0.02–0.38; p = 0.001). Patients with brain metastases chose hospice (OR 12.37; 95 % CI 2.25–68.13; p = 0.004). Furthermore, having a caregiver was associated with prolonged survival (hazard ratio 0.62; 95 % CI 0.39–0.97; p = 0.035).
Conclusion
Familial factors such as having children and caregivers significantly influenced the place of EOL care for terminally ill breast cancer patients.
Similar content being viewed by others
References
National Cancer Center Cancer Information Service. Japanese cancer statistics [in Japanese]. National Cancer Center, Tokyo, Japan. 2015. Available at: http://ganjoho.jp/public/statistics/index.html. Accessed May 23, 2015.
Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3:287–300.
Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458–65.
Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353–63.
Bruera E, Russell N, Sweeney C, et al. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol. 2002;20:2127–33.
Burge F, Lawson B, Johnston G. Trends in the place of death of cancer patients, 1992-1997. CMAJ. 2003;168:265–70.
Sanjo M, Miyashita M, Morita T, et al. Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan. Ann Oncol. 2007;18:1539–47.
Yamagishi A, Morita T, Miyashita M, et al. Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study. Am J Hosp Palliat Care. 2008;25:412–8.
Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–8.
Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22:3438–40.
Alonso-Babarro A, Bruera E, Varela-Cerdeira M, et al. Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol. 2011;29:1159–67.
Grendarova P, Sinnarajah A, Trotter T, et al. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010. Support Care Cancer. 2015;23:3059–67.
O’Connor TL, Ngamphaiboon N, Groman A, et al. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med. 2015;18:50–5.
Morita T, Oyama Y, Cheng SY, et al. Palliative care physicians’ attitudes toward patient autonomy and a good death in East Asian Countries. J Pain Symptom Manage. 2015;50(190–199):e191.
Morita T, Akechi T, Ikenaga M, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23:2637–44.
Okamura H, Uchitomi Y, Sasako M, et al. Guidelines for telling the truth to cancer patients. Japanese National Cancer Center. Jpn J Clin Oncol. 1998;28:1–4.
Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci. 1997;809:290–9.
Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.
Braga S, Miranda A, Fonseca R, et al. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis. Psycho-oncology. 2007;16:863–8.
Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol. 2009;20:1555–9.
Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–91.
Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–6.
Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30:4380–6.
Akiyama M, Takebayashi T, Morita T, et al. Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan. Support Care Cancer. 2012;20:923–31.
Morita T, Miyashita M, Shibagaki M, et al. Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage. 2006;31:306–16.
Nishie H, Mizobuchi S, Suzuki E, et al. Living will interest and preferred end-of-life care and death locations among Japanese adults 50 and over: a population-based survey. Acta Med Okayama. 2014;68:339–48.
Acknowledgments
This study was supported by a public grant from the Ministry of Health, Labor, and Welfare of Japan (H24-GanRinSho-Wakate-001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no potential conflict of interest.
About this article
Cite this article
Harano, K., Yonemori, K., Hirakawa, A. et al. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study. Breast Cancer 23, 797–806 (2016). https://doi.org/10.1007/s12282-015-0643-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-015-0643-6